Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hepatitis E virus: an emerging disease].

Jean-Marie Péron1, Jean-Michel Mansuy, Jacques Izopet

  • 1Service d'Hépato-gastro-entérologie, Fédération digestive, Hôpital Purpan, CHU Toulouse. Peron.jm@chu-toulouse.fr

Sante (Montrouge, France)
|April 21, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genotypic and phenotypic characteristics of CXCR4-using transmitted/founder HIV-1 envelope glycoproteins.

Journal of virology·2026
Same author

Evidence of Rat Hepatitis E Virus Circulation through Wastewater Surveillance, Central Argentina.

Emerging infectious diseases·2026
Same author

Delta Describe, the French Collaborative Project: The Profile and Management of Hepatitis Delta Patients in Metropolitan France.

Viruses·2026
Same author

Evaluation of a New Automated Platform for the Detection and Quantification of HEV RNA.

Journal of medical virology·2026
Same author

Two decades of hepatitis E in solid organ transplantation: A retrospective monocentric analysis.

Hepatology (Baltimore, Md.)·2026
Same author

A Computational Structural Analysis of Host Insertions in the Polyproline Region of the Hepatitis E Virus pORF1 Polyprotein.

Viruses·2026
Same journal

[Cannabis use in a central region of Tunisia].

Sante (Montrouge, France)·2012
Same journal

[Factors associated with overweight and obesity in children in Ouagadougou (Burkina Faso)].

Sante (Montrouge, France)·2012
Same journal

[Epidemiology, microbiology, and outcomes of septicemia in children treated at the Charles de Gaulle University Pediatric Hospital in Burkina Faso].

Sante (Montrouge, France)·2012
Same journal

[Medical audit of neonatal deaths with the "three delay" model in a pediatric hospital in Ouagadougou].

Sante (Montrouge, France)·2012
Same journal

[Controlling caesarean-site infection. Collaboration between the obstetric and hospital hygiene departments].

Sante (Montrouge, France)·2012
Same journal

[Sickle cell disease is one century old: what about therapeutics?].

Sante (Montrouge, France)·2012
See all related articles

Hepatitis E virus (HEV) causes sporadic and epidemic infections, primarily through fecal-oral transmission. Autochthonous HEV cases in France present unique challenges, including older onset and severe prognoses, especially in immunocompromised individuals.

Area of Science:

  • Virology
  • Infectious Diseases
  • Public Health

Context:

  • Hepatitis E virus (HEV) is a significant global pathogen, causing both epidemic and sporadic infections.
  • Transmission occurs mainly via the fecal-oral route, with zoonotic potential.
  • Autochthonous HEV cases are increasingly reported in non-endemic regions like France.

Purpose:

  • To highlight the evolving epidemiology of Hepatitis E virus (HEV) in France.
  • To differentiate autochthonous HEV from endemic cases.
  • To emphasize the need for considering HEV in unexplained acute hepatitis.

Summary:

  • HEV is a non-enveloped RNA virus with four genotypes, transmitted fecal-orally, posing risks from animals.
  • Sporadic autochthonous HEV cases in France differ from endemic forms, often affecting older individuals, having a more severe prognosis, and potentially leading to chronic illness in immunocompromised patients.

Related Experiment Videos

  • Diagnosis of HEV should be considered for all unexplained acute hepatitis cases in France, utilizing RT-PCR testing.

    • Impact:

    • Increased awareness and timely diagnosis of Hepatitis E virus (HEV) in France.
    • Improved management strategies for severe and chronic HEV infections, particularly in immunocompromised populations.
    • Enhanced public health surveillance for HEV transmission in non-endemic areas.